Related Experiment Video
Updated: Feb 2, 2026
06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
3.1K
Novel Vaccine Candidates against Tuberculosis
Zhihao Li1, Changping Zheng1, Marco Terreni2
1Sorbonne Universite, CNRS, Institut Parisien de Chimie Moleculaire (UMR 8232), 4 Place Jussieu, 75005 Paris, France.
Current Medicinal Chemistry
|November 27, 2018
Summary
Tuberculosis (TB) remains a major global health threat due to drug resistance and ineffective vaccines. This review covers TB prevalence, immune responses, and advancements in novel vaccine development, including LAM-based candidates.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Tuberculosis (TB) is a leading cause of death globally, ranking above AIDS.
- Existing treatments face challenges from Multi-Drug Resistance (MDR) and Extensively-Drug Resistance (XDR).
- The current Bacillus Calmette-Guérin (BCG) vaccine offers insufficient protection.
Purpose of the Study:
- To provide a comprehensive review of Tuberculosis (TB) prevalence.
- To discuss the human immune system's response to TB.
- To summarize recent advancements in TB vaccine research and development.
Main Methods:
- Literature review of TB prevalence and epidemiology.
- Analysis of immune responses against TB.
- Review of ongoing TB vaccine clinical trials and LAM-based candidates.
Main Results:
- TB continues to be a significant global health issue with limited treatment options.
- Novel vaccine candidates are crucial for effective TB prevention and immunotherapy.
- Several promising vaccines are in clinical trials, including lipoarabinomannan (LAM)-based approaches.
Conclusions:
- There is an urgent need for improved TB vaccines due to drug resistance and BCG limitations.
- Research is progressing with various vaccine candidates in clinical trials.
- LAM-based vaccines show potential for future TB prevention and treatment strategies.
Related Concept Videos
01:51Vaccinations
51.7K
Overview
51.7K
01:30Cancer Vaccines
1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K
01:29Pulmonary Tuberculosis I
958
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
958
01:28Pulmonary Tuberculosis II
1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
01:28Pulmonary Tuberculosis V
622
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
622
01:31Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K